Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture.

Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture.
复制标题

由培养的内皮细胞释放的肽能物质引起持续的冠状血管收缩。

DOI:
--
复制
发表时间:
1986
影响因子:
3.5
通讯作者:
R. O'Brien
R. O'Brien
中科院分区:
医学2区
文献类型:
--
作者:
M. Gillespie;J. O. Owasoyo;I. Mcmurtry;R. O'Brien

文献摘要

被引文献

相似文献

最近的报道表明,培养的内皮细胞向培养基中释放一种(或多种)收缩动脉平滑肌分离制剂的物质[内皮源性收缩因子(EDCF)]。为了评价EDCF的冠状动脉和心脏效应,在非再循环系统中用Krebs-Henseleit溶液反灌注的离体兔心脏用无血清最低必需培养基(载体)或浓缩在最低必需培养基(EDCF)中的主动脉内皮细胞上清液的推注(100-600微升)进行挑战。EDCF,而不是其媒介物,产生剂量依赖性冠状血管收缩,不伴有左心室收缩或心率的变化。在15分钟的观察期内,收缩反应持续良好,阻力几乎没有或没有下降。硝普钠可抑制EDCF引起的血管收缩,并可逆转EDCF引起的血管收缩。无论是meclutamate或乙胺嗪影响EDCF诱导的升压反应,从而否定了花生四烯酸代谢产物的作用。EDCF诱导的冠状动脉血管收缩也不受α-肾上腺素能、组胺能或肾上腺素能受体阻断的影响。EDCF与胰蛋白酶共同孵育可明显减弱其升压作用,提示EDCF可能是一种多肽。血管紧张素或P物质的作用被排除,然而,saralasin未能影响EDCF诱导的收缩,因为P物质在灌注的兔心脏制备中是无活性的。我们的结论是一种物质(或多种物质),可能是一种肽,从培养的内皮细胞中释放,通过一种未知的机制引起持续的冠状血管收缩。
Recent reports have shown that cultured endothelial cells release into the culture medium a substance (or substances) that contracts isolated preparations of arterial smooth muscle [endothelial-derived constrictor factor (EDCF)]. To evaluate the coronary and cardiac effects of EDCF, isolated rabbit hearts retroperfused in a nonrecirculating system with Krebs-Henseleit solution were challenged with bolus injections (100-600 microliter) of either serum-free minimum essential medium (vehicle) or aortic endothelial cell supernates concentrated in minimum essential medium (EDCF). EDCF, but not its vehicle, produced dose-dependent coronary vasoconstriction unaccompanied by changes in left ventricular contraction or heart rate. The constrictor responses were remarkably well sustained with little or no decrement in resistance occurring over a 15-min observation period. Nitroprusside inhibited the development of and reversed on-going vasoconstriction evoked by EDCF. Neither meclofenamate nor diethylcarbamazine influenced EDCF-induced pressor responses, thereby negating a role for arachidonic acid metabolites. Coronary vasoconstriction induced by EDCF also was unaffected by blockade of alpha-adrenergic, histaminergic or serotonergic receptors. Incubation of EDCF with trypsin attenuated the pressor effects markedly, suggesting that EDCF may be a peptide. Roles for angiotensin or substance P were ruled out, however, as saralasin failed to influence EDCF-induced constriction and since substance P was inactive in the perfused rabbit heart preparation. We conclude that a substance (or substances), probably a peptide, released from cultured endothelial cells provokes sustained coronary vasoconstriction by an unknown mechanism.